Connect with us

EU Politics

Explainer: The Eastern Partnership policy beyond 2020

Published

on

Why is the EU adopting a new policy framework for the Eastern Partnership beyond 2020?

With the current Eastern Partnership (EaP) “20 Deliverables for 2020” framework expiring at the end of this year, a wider reflection on its future was needed. Coinciding with the 10th anniversary of the launch of the Partnership, the European Council tasked the European Commission and the High Representative in June last year to present a further set of long-term policy objectives beyond 2020 in view of the next Eastern Partnership Summit this June.

The Eastern Partnership aims to strengthen and deepen political and economic relations between the European Union, its Member States and the six Eastern partner countries and remains a cornerstone of EU’s foreign policy. The new policy framework will strengthen resilience in partner countries in light of today’s challenges, foster sustainable development and deliver tangible results for citizens. It will also contribute to building a stronger Europe in the world.

What is the new EaP policy framework proposing? What is different/new?

Over the past ten years, the Eastern Partnership has delivered concrete, positive results for citizens in the EU and in its eastern neighbourhood. Based on the results of an extensive consultation process and the building on these achievements, the new EaP policy outlines five flexible and connected long-term policy objectives that aim at responding to new priorities, strengthening resilience to address common challenges, foster sustainable development and continue to deliver concrete results to citizens, namely:

  1. Together for resilient, sustainable and integrated economies;
  2. Together for accountable institutions, the rule of law and security;
  3. Together towards environmental and climate resilience;
  4. Together towards a resilient digital transformation; and
  5. Together for resilient, fair and inclusive societies;

Our joint efforts will ensure that the EU and partners work together across the five objectives to better support the ecological and digital transformations, promote sustainable development and provide more decent job and economic opportunities, in particular for young people, and to promote gender equality.

What do you mean by strengthening resilience? 

Resilience is multi-dimensional and contributes towards stability, security and prosperity. The EaP policy beyond 2020 focuses on the modernisation and implementation of sustainable reforms, which are key for investing in a resilient economy, democracy, environment and climate, and society.

Strengthening the resilience of the Eastern Partnership will be the core of our new policy in order to address jointly the common challenges in a changing global environment. This has also been reflected in the outcomes of the structured consultation.

When will the implementation of the new policy framework start? How much money will the EU invest? 

The EaP Summit among Heads of State and Government in June this year will be an opportunity to endorse the proposed long-term policy framework and give a mandate to develop a new set of tangible deliverables, building on the current “20 Deliverables for 2020” agenda. The Commission and the European External Action Service will then propose realistic and measurable result-oriented deliverables in the second part of 2020, after further in-depth discussions with Member States, partners and key stakeholders.

The EaP policy beyond 2020 will guide our future joint work and assistance and set the basis for the future programming of the EU cooperation with partner countries at regional level, but also with clear indications for bilateral cooperation. As discussions on the future Multiannual Financial Framework are still ongoing, the specific amount of money to be invested in both bilateral and regional cooperation is still to be determined.

How will the EU help create jobs and opportunities in Eastern partner countries?

To support the creation of job and economic opportunities in partner countries, the EU is proposing to further deepen the economic integration with and among partner countries, and to increase trade, which has nearly doubled in the last decade. The EU will support the full implementation of the Deep and Comprehensive Free Trade Areas (DCFTAs) with Ukraine, Georgia and Moldova, and also encourage enhanced cooperation with non- DCFTA countries, for example through sectoral trade facilitation arrangements of common interest involving all partners.  

How will the new EaP policy address on issues of climate change and environmental protection?

Joint work on combating climate change, ensuring more opportunities for greening societies and economies and fostering a circular economy is an integral part of the Eastern Partnership policy framework beyond 2020. The EU will help partner countries to fulfil their nationally determined contributions to the Paris Agreement and modernise their economies, reducing their carbon footprint and moving towards climate neutrality, while acknowledging the investment challenges.

How will the new EaP policy address digital transformation?

As indicated in the Strategy on Shaping Europe’s digital future, the digital transformation can enable growth and drive sustainable development for both the EU and partner countries. This is why the EU will invest in the digital transformation of the partner countries, in line with EU legislation and best practice, and aim to extend the benefits of the Digital Single market to them. This will allow for better access to digital infrastructure and services, better public services and administration for citizens, the extension of broadband infrastructures especially in regions and local areas, and a strengthened e-Governance.

How will the new EaP policy address challenges to governance, rule of law and the fight against corruption? 

Good governance, democracy, the rule of law and human rights are fundamental values that lie at the heart of the EU’s relationship with partner countries and of the Eastern Partnership itself. They are also preconditions for a functioning market economy and for sustainable growth. In particular, the rule of law is a key factor in ensuring an effective business environment and an important consideration in attracting foreign direct investment.

The EU will keep working together with the governments of partner countries to strengthen the rule of law and anti-corruption mechanisms, as well as the independence, impartiality, efficiency and accountability of justice systems, and to reinforce public administration. The EU remains committed to promote and defend human rights in the region, including through its support to civil society and media. 

There needs to be a renewed commitment to the fundamentals of the partnership and better measure the impact of judicial reforms. In this context, the EU will consider progress in rule of law reforms when deciding on assistance. Serious or prolonged stagnation or even backsliding in reform implementation should lead to EU funding being decreased, with the exception of support to civil society.  

How will the new EaP policy address challenges to civil society space? 

The Eastern Partnership goes beyond relations with governments. Partnerships with other key stakeholders, such as civil society organisations are equally important.   Working with civil society has become an indispensable element of the Eastern Partnership and plays a vital role in promoting democracy, the rule of law and advancing key reforms.

In this regard, the EaP Civil Society Forum is a unique, multilateral platform for experience-sharing, mutual learning, support and partnership building. The EU will also further develop strategic partnerships with key civil society organisations to strengthen cooperation, build up the leadership skills of civil society activists, and engage with social partners such as trade unions and employers’ organisations.

Will the EU continue to tackle fake news and disinformation from Russia?

In the wake of growing disinformation against EU values in recent years, the EU has worked to put in place a stronger and more strategic approach to communication. We have strengthened the EU’s communication in partner countries through clear, tailor-made messaging and raising awareness of the positive impact of EU policies and actions to people across the region. Under the new Eastern Partnership framework, there will be a renewed focus on outreach to youth. Strategic communication is crucial for building resilience and is a core duty for policy-makers at the service of citizens.

The EU will also consider providing training opportunities and capacity building to the partner countries, including on countering hybrid threats, where appropriate.

You say the EU will work with the Eastern partners to tackle common challenges, what about Coronavirus? 

The concept of resilience is even more important against the background of the ongoing COVID-19 pandemic. The EU will support partner countries in the area of public health, in particular in the modernisation of medical facilities, e-health, training of medical staff and providing affordable medical care and promoting access. This will include support in better addressing communicable and non communicable diseases as in the case of the coronavirus disease (COVID-19).

The EU is also looking at what can be done in terms of mitigating the socio-economic consequences of the crisis, for example how to adjust SME support schemes to take into account liquidity and other challenges they face. When it comes to state aid, the Commission allows more flexibility in the EU state aid rules, to allow for swift support for companies in the Member States. The flexibility is by extension valid also for the partners, while staying within the provisions of the Association Agreements and DCFTAs.

What has the EaP delivered in the past 10 years? 

Over the past 10 years, the Eastern Partnership has progressed based on common values, mutual interests and commitments, as well as on shared ownership and responsibility. This strategic partnership has matured and evolved with achievements such as Association Agreements (including Deep and Comprehensive Free Trade Areas), a Comprehensive Enhanced Partnership Agreement, Visa Facilitation and Readmission Agreements, visa liberalisations and Partnership priorities, which are today the cornerstones of our relations and cooperation.

Trade between the EU and Eastern partner countries has nearly doubled in the last decade. The EU is the first trading partner for Azerbaijan, Georgia, Moldova and Ukraine and second biggest for Armenia and Belarus. In the period between 2016 and 2019, trade volumes between the EU and Armenia went up by 27%, by 55% with Azerbaijan, by 40% with Belarus, by 7% with Georgia, by 42% with Moldova and by 50% with Ukraine.

Furthermore, over 125,000 small- and medium-sized companies in the Eastern partners have benefitted from EU funding, creating or sustaining more than 250,000 jobs. More than €60 million was allocated to almost 7,250 SMEs led by women and 290 women entrepreneurs received training through the EU4Business initiative in 2018 alone.

In the area of transport connectivity, a €20 million technical assistance facility to help implementation of the extension of the Trans-European Transport Network has been set up. The EU’s TENT-T extension foresees 4,800 km of new and rehabilitated roads and railways by 2030, which will open new opportunities for economic development and exchanges between the EU and Eastern partner countries and amongst themselves.

In terms of investments to reduce greenhouse gas emissions, through the Eastern Europe Energy Efficiency and Environment Partnership, the E5P Fund has provided more than €150 million in investment grants to 36 projects benefitting 8 million people. This has made it possible to leverage almost €800 million in total investments.

The Eastern Partnership is also delivering for the youth and researchers. The EU has supported 100 projects supporting civic engagement and entrepreneurship amongst the young people and 23.000 young people in the region have benefitted from EU4Youth grants to support six large-scale projects to boost youth employment, their employability and transition to work and 915 researchers from the region benefit from the Marie Curie scheme.

Since 2016, 32.000 students and academic staff from the Eastern partner countries have participated in academic exchanges thanks to Erasmus+ and 46.000 young people were involved in other exchanges, including volunteering.

The structured consultation in 2019 confirmed that the Eastern Partnership is robust and delivering concrete benefits to citizens. The results-oriented approach “20 deliverables for 2020” has delivered notably on stronger economy, stronger connectivity and stronger society. There have been some achievements when it comes to stronger governance, but more remains to be done on the rule of law, the fight against corruption, independent media and civil society space.

Continue Reading
Comments

EU Politics

EU proposes a strong multilateral trade response to the COVID-19 pandemic

Published

on

EU has submitted its proposal seeking the commitment of World Trade Organization (WTO) members for a multilateral trade action plan to expand the production of COVID-19 vaccines and treatments, and ensure universal and fair access. With this proposal to the WTO, divided in two communications, the EU underlines the WTO’s central role in the response to the COVID-19 pandemic and urges fellow WTO members to agree on a set of commitments, including on intellectual property rights.

President von der Leyen said: “The EU has actively shown solidarity with the world since the beginning of the pandemic. The European Union authorized exports of around half of the total amount of vaccines produced in Europe. Our immediate, urgent goal is to ensure equitable access for low – and middle-income countries, to share vaccines wider and faster. And we continue to help ramping up production. The EU proposes concrete short and medium term solutions to ensure universal access at affordable prices. I am looking forward to discuss with the G7 leaders next week how to achieve this goal. Beyond the current crisis, it is important to ensure global preparedness for future pandemics: diversifying manufacturing so that it is not centralised only in a handful of countries and strengthening the resilience of the healthcare infrastructure in least developed countries”.

Executive Vice-President and Commissioner for Trade Valdis Dombrovskis said: “The pandemic is still with us and there can be no room for complacency. We need to urgently concentrate on proposals that accelerate the equitable distribution of COVID-19 vaccines worldwide. In this respect, a strong multilateral trade response could deliver a huge boost in the fight against COVID-19. In reality, the main problem at this moment relates to the lack of sufficient manufacturing capacity to rapidly produce the required quantities. The objective must be to ensure that any available and adequate manufacturing capacity anywhere in the world is used for the COVID-19 vaccines production.”

More on the EU’s proposal

The EU calls on governments to:

  1. Ensure that COVID-19 vaccines, treatments and their components can cross borders freely;
  2. encourage producers to expand their production, while ensuring that those countries most in need of vaccines receive them at an affordable price, and;
  3. facilitate the use of compulsory licensing within the WTO’s existing Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The TRIPS Agreement already provides this flexibility, which is a legitimate tool during the pandemic that can be used swiftly where needed

The first element aims to limit the use of export restrictions and keep supply chains open. Vaccine-producing countries should be ready to export a fair share of their domestic production. Supply chains are highly interconnected and should not be disrupted. In addition, the EU considers that supplies to the COVAX Facility should never be restricted, and no measures should limit trade in inputs necessary for the production of COVID-19 vaccines and treatments. 

The second element calls on governments to strongly encourage and support vaccine manufacturers and developers to expand production and ensure the affordable supply of vaccines to low- and middle-income countries. Such actions could include licensing agreements, the sharing of expertise, tiered pricing including non-profit sales to low-income countries, contract manufacturing and new investments in manufacturing facilities in developing countries. The EU expects all vaccine producers and developers to make concrete pledges that increase supplies to vulnerable developing countries. In this regard, the EU welcomes the commitment of companies such as BioNTech and Pfizer, Johnson & Johnson and Moderna, which have already committed to delivering 1.3 billion doses this year to low-income countries at no profit and to middle-income countries at lower cost.

The third element, on intellectual property, sets out that voluntary licences are the most effective instrument to facilitate the expansion of production and sharing of expertise. Where voluntary cooperation fails, compulsory licences, whereby a government grants a targeted licence allowing a willing producer to make a vaccine without the consent of a patent holder, are a legitimate tool in the context of a pandemic. The EU considers that all WTO members should be ready to:

  • agree that the COVID-19 pandemic is an exceptional circumstance of national emergency, and that the requirement to negotiate with the rights’ holder may be legitimately waived where needed;
  • support manufacturers that are ready to produce vaccines and/or treatments at affordable prices under a compulsory licence so that the level of remuneration paid by the manufacturer to the patent holder reflects such affordable prices;
  • agree that the compulsory licence could cover any exports destined to countries that lack manufacturing capacity, including via the COVAX facility.

The EU is also tabling a dedicated communication on intellectual property to the WTO body in charge of implementing the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Council). Here, the EU provides more detail and clarity on each of the three points on intellectual property and links them with the specific provisions in the TRIPS Agreement. As regards the broad waiver proposed by a number of WTO members, the European Commission, while ready to discuss any option that helps end the pandemic as soon as possible, is not convinced that this would provide the best immediate response to reach the objective of the widest and timely distribution of COVID-19 vaccines that the world urgently needs. Today’s proposals aim at achieving that objective in a swift and effective manner.

Continue Reading

EU Politics

EU Digital COVID Certificate: Parliament and Council reach agreement

Published

on

Photo: Lukas Souza/Unsplash

The Commission welcomes today’s provisional political agreement between the European Parliament and the Council on the Regulation governing the EU Digital COVID Certificate. This means that the certificate (previously called the Digital Green Certificate) is well on track to be ready end of June, as planned. Today’s agreement has been reached in record time just two months after the Commission’s proposal. The negotiations on the certificate for the Commission have been led by Commissioner Didier Reynders in close cooperation with Vice-Presidents Vera Jourová and Margaritis Schinas and Commissioners Thierry Breton, Stella Kyriakides, and Ylva Johansson.

Welcoming this swift progress, President Ursula von der Leyen said:

“We are delivering on our commitment to have the EU Digital COVID Certificate up and running before the summer. European citizens are looking forward to travelling again, and today’s agreement means they will be able to do so safely very soon.

The EU Digital COVID Certificate is free of charge, secure and accessible to all. It will cover vaccination, test and recovery offering different options to the citizens. It fully respects citizens’ fundamental rights, including protection of personal data.

All EU citizens have a fundamental right to free movement in the EU. The EU Digital COVID Certificate, available in paper or digital format, will make it easier for Europeans to travel – whether to see their families and loved ones or to get some well-deserved rest.

We would like to thank the European Parliament and the Portuguese Presidency for their dedication, perseverance and immense work at record speed to find an agreement on the proposal we presented.

Work still remains. At EU level, the system will be ready in the next few days. It is now crucial that all Member States press ahead with the roll-out of their national systems to ensure that the system can be up and running as soon as possible. This is what EU citizens rightly expect.

Today’s agreement has demonstrated that with the commitment and cooperation of all, the EU Digital COVID Certificate will be available on time.”

The EU Digital COVID Certificate – key features

Following the agreement reached by the European Parliament and the Council, the EU Digital COVID Certificate:

  • will cover vaccination, test and recovery;
  • will be available in a digital and paper-based format, depending on the choice of the recipients, and contain a digitally signed QR code;
  • will be free of charge, be obtained easily and also available to persons vaccinated before the EU Digital COVID Certificate Regulation has entered into force;
  • may also be used by Member States for national purposes, if this is provided for in national law.
  • Member States shall refrain from imposing additional travel restrictions on the holders of an EU Digital COVID Certificate, unless they are necessary and proportionate to safeguard public health.
  • The Commission will also mobilise €100 million to support Member States in providing affordable tests.

Next Steps

The political agreement will now have to be formally adopted by the European Parliament and the Council. The Regulation will enter into force on 1 July, with a phasing-in period of six weeks for the issuance of certificates for those Member States that need additional time.

In parallel, the Commission will continue to support the Member States in finalising their national solutions for the issuance and verification of EU Digital COVID Certificate, and to provide technical and financial support to Member States to on-board the gateway.

Background

On 17 March 2021, the European Commission presented a proposal to create an EU COVID certificate to facilitate the safe free movement of citizens within the EU during the COVID-19 pandemic. At the Commission’s request, the Parliament voted in favour of the activation of the urgent procedure for the two proposals on 25 March. The Council adopted its negotiating position on 14 April, and the Parliament did so on 29 April. On 20 May co-legislators reached provisional agreement on this file.

In parallel to the legislative process, important progress was already made on the technical side. The EU Gateway, which allows to verify certificates across borders, is ready and will go live as of June. Successful pilot tests took place with 17 Member States and Iceland during the last two weeks, further five Member States will test next week.

The Commission also provide open source reference software to support Member States to develop their national solution to issue certificates, to scan and check the QR codes, and a reference wallet for storage.

Previously, on 21 April, technical specification guidelines were adopted by Member States representatives in the eHealth Network, a voluntary network connecting national authorities responsible for eHealth. They are building on the close work of the Commission with the Member States, having resulted in first guidelines adopted in January and updated on 12 March, and a trust framework outline agreed on 12 March 2021. In addition, a common design template was developed in the eHealth network.

Continue Reading

EU Politics

Coronavirus: EU Strategy for the development and availability of therapeutics

Published

on

The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Today’s Strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.

It is part of the strong European Health Union, in which all EU countries prepare and respond together to health crises and ensure the availability of affordable and innovative medical supplies – including the therapeutics needed to treat COVID-19.

The Strategy includes clear actions and targets, including authorising three new therapeutics to treat COVID-19 by October 2021 and possibly two more by end of the year. Concretely:

  • Research, development and innovation
    • Invest €90 million in population studies and clinical trials to establish links between risk factors and health outcomes to further inform public health policy and clinical management, including for long-COVID patients.
    • Set up a ‘therapeutics innovation booster’ by July 2021 to support the most promising therapeutics from preclinical research to market authorisation. It will build on current initiatives and investments in therapeutic development, working in a close cooperation with the European Health Emergency Preparedness and Response Authority (HERA) preparatory action on mapping therapeutics. It will therefore ensure the coordination of all research projects on COVID-19 therapeutics, stimulating innovation and boosting therapeutic development.
  • Access to and swift approval of clinical trials
    • Invest €5 million under the EU4Health programme to generate better, high-quality safety data in clinical trials, which will help produce robust results in a timely manner.
    • Provide EU countries with financial support of €2 million under the EU4Health 2021 work programme for expedited and coordinated assessments to facilitate approval of clinical trials.
    • Explore how to support developers of therapeutics to build capacity to produce high-grade material for clinical trials.
  • Scanning for candidate therapeutics
    • Invest €5 million to map therapeutics and diagnostics to analyse development phases, production capacities and supply chains, including possible bottlenecks.
    • Establish a broader portfolio of 10 potential COVID-19 therapeutics and identify five of the most promising ones by June 2021.
  • Supply chains and delivery of medicines
    • Fund a €40 million preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, which in turn will become over time an important asset for the future the European Health Emergency Preparedness and Response Authority (HERA).
  • Regulatory flexibility
    • Authorise at least three new therapeutics by October and possibly two more by the end of the year and develop flexible regulatory approaches to speed up the assessment of promising and safe COVID-19 therapeutics.
    • Start seven rolling reviews of promising therapeutics by end-2021, subject to research and development outcomes.
  • Joint procurement and financing
    • Launch new contracts for the purchase of authorised therapeutics by the end of the year.
    • Secure faster access to medicines with shorter administrative deadlines.
  • International cooperation to make medicines available to all
    • Reinforce engagement for the therapeutics pillar of the Access to COVID-19 Tools Accelerator.
    • Boost ‘OPEN’ initiative for international collaboration.

Next Steps

The Commission will draw up a portfolio of 10 potential COVID-19 therapeutics and by June 2021, identify the five most promising ones. It will organise matchmaking events for industrial actors involved in therapeutics to ensure enough production capacity and swift manufacturing. New authorisations, rolling reviews and joint procurement contracts will be up and running before the end of the year.

The therapeutics innovation booster, matchmaking events and preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, will feed into the HERA, for which a proposal is due later in the year. The pilot project on access to health data will feed into the European Health Data Space proposal expected later this year.

Members of the College said:

Vice-President for Promoting our European Way of Life, Margaritis Schinas, said: “The situation in many intensive care units across the continent remains critical. We need to focus both on vaccines and therapeutics, as two powerful and complementary ways to combat COVID-19. But currently we have only one authorised medicine to treat COVID-19. By acting on better availability of medicines today, we are making sure patients receive the treatments they need while also preparing our future biomedical preparedness. A coordinated strategy on quick access to therapeutics will boost our strategic autonomy and contribute to a strong Health Union.”

Commissioner for Health and Food Safety, Stella Kyriakides, said: “Vaccinations save lives, but they cannot yet eradicate COVID-19. We need a strong push on treatments to limit the need for hospitalisation, speed up recovery times, and reduce mortality. Patients in Europe and across the world should have access to world-class COVID-19 medicines. This is why we have set a very clear goal: by October, we will develop and authorise three new effective COVID-19 therapeutics that can have the potential to change the course of the disease. We will do so by investing in research and innovation, the identification of new promising medicines, ramping up production capacity and supporting equitable access. Our Therapeutics Strategy is a strong European Health Union in action.”

Commissioner for Innovation, Research, Culture, Education and Youth, Mariya Gabriel, said: “By increasing vaccine availability across Europe, more and more Europeans are now protected against COVID-19. In the meantime, the development of innovative medicines to treat coronavirus patients remains a priority when it comes to saving lives. Research and innovation is the first step to finding effective and safe therapeutics, which is why we are proposing to establish a new COVID-19 ‘therapeutics innovation booster’ and will invest € 90 million in population studies and clinical trials.

Background

The Strategy on COVID-19 therapeutics complements the EU strategy for COVID-19 vaccines from June 2020 and builds on ongoing work by the European Medicines Agency and the Commission to support research, development, manufacturing and deployment of therapeutics.

The Strategy forms part of a strong European Health Union, using a coordinated EU approach to better protect the health of our citizens, equip the EU and its Member States to better prevent and address future pandemics, and improve the resilience of Europe’s health systems.

Continue Reading

Publications

Latest

Trending